AMRI uncertain over DuPont contract

Drug discovery services company Albany Molecular (AMRI) said that in 2002, its contract with DuPont Pharmaceuticals may be continued at a significantly reduced level. For the 9 months ended Sept. 30, AMRI said the DuPont contract accounted for $7.8 million (19.1%) of its $40.7 million in contract revenue. ...